These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30074276)

  • 21. Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma.
    Miura S; Mitsuhashi N; Shimizu H; Kimura F; Yoshidome H; Otsuka M; Kato A; Shida T; Okamura D; Miyazaki M
    BMC Cancer; 2012 Feb; 12():56. PubMed ID: 22309595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTX promotes breast cancer migration and invasion by recruiting ATF4 to upregulate FGF19.
    Xue T; Wang X; Pan X; Liu M; Xu F
    Cell Signal; 2024 Oct; 122():111309. PubMed ID: 39053672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma.
    Gao L; Lang L; Zhao X; Shay C; Shull AY; Teng Y
    Oncogene; 2019 Mar; 38(13):2394-2404. PubMed ID: 30518874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Src is essential for the endosomal delivery of the FGFR4 signaling complex in hepatocellular carcinoma.
    Shin JY; Ahn SM
    J Transl Med; 2021 Apr; 19(1):138. PubMed ID: 33794926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1.
    Guo C; Zhou N; Lu Y; Mu M; Li Z; Zhang X; Tu L; Du J; Li X; Huang D; Xu Q; Zheng X
    Biomed Pharmacother; 2024 Jan; 170():115955. PubMed ID: 38048735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma.
    Lin ZZ; Hsu C; Jeng YM; Hu FC; Pan HW; Wu YM; Hsu HC; Hu MC; Cheng AL
    Liver Int; 2019 Sep; 39(9):1682-1691. PubMed ID: 30698907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin Suppresses Oral Squamous Cell Carcinomas Migration and Invasion through Blocking FGF19/FGFR 4 Signaling Pathway.
    Wang L; Su Y; Choi WS
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC.
    Chen X; Chen J; Feng W; Huang W; Wang G; Sun M; Luo X; Wang Y; Nie Y; Fan D; Wu K; Xia L
    Theranostics; 2023; 13(4):1401-1418. PubMed ID: 36923538
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
    Luo Y; Yang C; Lu W; Xie R; Jin C; Huang P; Wang F; McKeehan WL
    J Biol Chem; 2010 Sep; 285(39):30069-78. PubMed ID: 20657013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer.
    Sasaki N; Gomi F; Yoshimura H; Yamamoto M; Matsuda Y; Michishita M; Hatakeyama H; Kawano Y; Toyoda M; Korc M; Ishiwata T
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease.
    Garcia-Recio S; Thennavan A; East MP; Parker JS; Cejalvo JM; Garay JP; Hollern DP; He X; Mott KR; Galván P; Fan C; Selitsky SR; Coffey AR; Marron D; Brasó-Maristany F; Burgués O; Albanell J; Rojo F; Lluch A; de Dueñas EM; Rosen JM; Johnson GL; Carey LA; Prat A; Perou CM
    J Clin Invest; 2020 Sep; 130(9):4871-4887. PubMed ID: 32573490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
    Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization.
    Shen L; Wang C; Ren R; Liu X; Zhou D; Chen Y; Zhou Y; Lei J; Xiao Y; Zhang N; Zhao H; Li Y
    Inflamm Res; 2024 Sep; 73(9):1493-1510. PubMed ID: 38981913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer.
    Hong CS; Sun EG; Choi JN; Kim DH; Kim JH; Ryu KH; Shim HJ; Hwang JE; Bae WK; Kim HR; Kim KK; Jung C; Chung IJ; Cho SH
    Cancer Sci; 2020 Sep; 111(9):3268-3278. PubMed ID: 32533590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling.
    Tian S; Chen M; Wang B; Han Y; Shang H; Chen J
    Ann Hepatol; 2021; 20():100259. PubMed ID: 32980439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGF19 sustains the high proliferative ability of keratinocytes in psoriasis through the regulation of Wnt/GSK-3β/β-catenin signalling via FGFR4.
    Yu X; Yan N; Li Z; Hua Y; Chen W
    Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):761-769. PubMed ID: 31074061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma.
    Tao Z; Cui Y; Xu X; Han T
    Proc Natl Acad Sci U S A; 2022 Oct; 119(40):e2208844119. PubMed ID: 36179047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
    Yang C; Jin C; Li X; Wang F; McKeehan WL; Luo Y
    PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
    Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA
    Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.